1-4 of 4
Andreas Vogt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Simplified Synthesis of Novel Dictyostatin Analogues with In Vitro Activity against Epothilone B–Resistant Cells and Antiangiogenic Activity in Zebrafish Embryos

Laura L. Vollmer, Maria Jiménez, Daniel P. Camarco, Wei Zhu, Hikmat N. Daghestani, Raghavan Balachandran, Celeste E. Reese, John S. Lazo, Neil A. Hukriede, Dennis P. Curran, Billy W. Day, Andreas Vogt
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (6): 994–1006.
https://doi.org/10.1158/1535-7163.MCT-10-1048
Published: 08 June 2011
View article titled, A Simplified Synthesis of Novel Dictyostatin Analogues with <em>In Vitro</em> Activity against Epothilone B–Resistant Cells and Antiangiogenic Activity in Zebrafish Embryos
Open the PDF for A Simplified Synthesis of Novel Dictyostatin Analogues with <em>In Vitro</em> Activity against Epothilone B–Resistant Cells and Antiangiogenic Activity in Zebrafish Embryos in another window
Includes: Supplementary data
Journal Articles

Meayamycin inhibits pre–messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells

Brian J. Albert, Peter A. McPherson, Kristine O'Brien, Nancy L. Czaicki, Vincent DeStefino, Sami Osman, Miaosheng Li, Billy W. Day, Paula J. Grabowski, Melissa J. Moore, Andreas Vogt, Kazunori Koide
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (8): 2308–2318.
https://doi.org/10.1158/1535-7163.MCT-09-0051
Published: 14 August 2009
View article titled, Meayamycin inhibits pre–messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells
Open the PDF for Meayamycin inhibits pre–messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells in another window
Journal Articles

A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells

Andreas Vogt, Peter R. McDonald, Aletheia Tamewitz, Rachel P. Sikorski, Peter Wipf, John J. Skoko, III, John S. Lazo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (2): 330–340.
https://doi.org/10.1158/1535-7163.MCT-07-2165
Published: 15 February 2008
View article titled, A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells
Open the PDF for A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells in another window
Journal Articles

The Antisignaling Agent SC-ααδ9, 4-(Benzyl-(2-[(2,5-diphenyloxazole- 4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric Acid, Is a Structurally Unique Phospholipid Analogue with Phospholipase C Inhibitory Activity

Andreas Vogt, Katharine E. Pestell, Billy W. Day, John S. Lazo, Peter Wipf
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (11): 885–892.
Published: 01 September 2002
View article titled, The Antisignaling Agent SC-ααδ9, 4-(Benzyl-(2-[(2,5-diphenyloxazole- 4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric Acid, Is a Structurally Unique Phospholipid Analogue with Phospholipase C Inhibitory Activity
Open the PDF for The Antisignaling Agent SC-ααδ9, 4-(Benzyl-(2-[(2,5-diphenyloxazole- 4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric Acid, Is a Structurally Unique Phospholipid Analogue with Phospholipase C Inhibitory Activity in another window